Advanced Kidney Care - maximising choice, optimising care Symposium 2026

Please note: this event has passed

Course summary

Join us for a multidisciplinary day reviewing developments in Advanced Kidney Care. In 2026 this one-day face-to-face symposium returns with an exciting schedule relevant to all healthcare professionals involved in this vital phase of kidney care.

For more information please email ctukeducation@kcl.ac.uk.

Provisional Programme

Time	Session	Speakers / Chairs
08:30 – 09:00	Coffee & Registration
09:00 – 09:05	Welcome and Housekeeping	Lisa Ancliffe
09:05 – 10:50	Session 1	Session Chairs: Lisa Ancliffe & Heather Brown
09:05 – 09:35	Who’s Being Left Behind? Health Literacy and Digital Access in Kidney Care	Jo Henry, Lead Nurse for CKD & Hypertension, Royal Free London NHS Foundation Trust
	Optimising Physical Activity through Digital Inclusion in AKC	Christy Walklin, Clinical Lead Physiotherapist, King’s College Hospital NHS Foundation Trust
09:35 – 10:05	Balancing Risk and Benefit: Transplantation in Later Life	John Holland, Nephrology Specialty Trainee, Guys and St Thomas’s NHS Trust Foundation Trust
10:05 – 10:35	From Choice to Long-Term Success: Optimising Home HD	Suzanne Forbes, Kidney Consultant, Barts Health NHS Foundation Trust
10:35 – 10:50	Patient story – “What I wish I had known before reaching Advanced Kidney Care”	Patient 1 (KCH)
10:50 – 1:15	Coffee break and networking
11:15 – 13:10	Session 2	Session chairs: Rosie Donne & Juliet Briggs
11:15 – 12:05 FMRI and Phoenix Pub	Case Studies 1 - The routine to the extraordinary: case studies of symptom control and crisis management in supportive care	Faculty
12:15 – 12:45	Right Access, Right Time: Planning for Dialysis in AKC	Damien Ashby, Nephrologist, Hammersmith Hospital
12:45 – 13:15	Not Too Early, Not Too Late: Timing, Choice and Communication when starting Kidney Replacement Therapy	Andrew Mooney, Consultant Nephrologist, Leeds Teaching Hospitals NHS Trust
13:15 – 14:05	Lunch break and networking
14:10 – 15:10	Session 3: Mini Mental Health Symposium	Session chairs: Eleri Wood & Jennifer Joslin
14:10 – 14:30	Caring for Patients with Severe Mental Illness: An MDT Challenge in AKC	Ed Beveridge, Clinical Director for Acute Adult Inpatients, North London NHS Foundation Trust
14:30 – 15:10	Case studies 2 – Learning from practical cases The overlap between CKD and severe mental health challenges: practical tips for kidney teams managing these patients	Faculty - Led by Chun Chiang Sin Fai Lam, Medical Lead for the Department of Psychological Medicine, King’s College Hospital NHS Foundation Trust
15:10 – 15:30	Coffee break and networking
15:30 – 17:20	Session 4	Session chairs: Rochelle Blacklock & Katie Vinen
15:30 – 15:45	Patient story 2	Patient 2 (GSTT)
15:45 – 16:15	Shaping the Future of Advanced Kidney Care: Transform AKC Update	Rosie Donne, Consultant in Renal Medicine, Salford Royal Foundation Trust
16:15 – 16:45	Supporting health in people living with obesity across the AKC pathway	Adrian Brown, Associate Professor (Principal Research Fellow) in Nutrition & Dietetics, University College London
16:45 – 17:15	Medicines in AKC – Too Many Pills, Too Little Understanding	Cathy Pogson, Specialist Renal Pharmacist, Portsmouth Hospitals University NHS Trust
17:15 – 17:20	Closing	Sharon Frame, Advanced Nurse Practitioner, Guys and St Thomas’s NHS Trust Foundation Trust

Download the provisional programme

Session Topics

By the end of the symposium, you will have learnt about:

Planning for the right access at the right time
When to start renal replacement therapy
Health literacy and digital access in Advanced Kidney Care
Optimising home haemodialysis
Caring for advanced kidney care patients with severe mental illness
Complex patients, complex decisions: best interests in Advanced Kidney Care
Medication in Advanced Kidney Care
Supporting health at higher body weight across the Advanced Kidney Care pathway
Transplantation in later life
Transform AKC update

Endorsements

	The UK Kidney Association The UK Kidney Association is a professional body for the UK kidney community that represents people working in clinical renal care, treating and caring for people with kidney disease, those working in research, or related sciences and fields and all allied healthcare professionals as members.
	ERA ERA’s aim is to reduce the burden of kidney disease by supporting basic and clinical research in the fields of clinical nephrology, dialysis, and renal transplantation. ERA organises annual congresses and supports fellowships, and CME courses. ERA publishes two official leading nephrology journals in Europe: Nephrology Dialysis Transplantation and Clinical Kidney Journal (open access). Join us for the 63rd ERA Congress on June 3-6, 2026
	The London Kidney Network The London Kidney Network is a collaborative initiative enhancing kidney care across London and Surrey through partnerships that improve patient outcomes and streamline services. Focused on innovation and equity, it supports quality improvements in areas like dialysis, transplantation, and chronic kidney disease prevention.
	Association of Nephrology Nurses ANN UK is a non-profit making membership organisation that aims to provide support for registered and non-registered nurses through education, research, evidence-based practice and by setting national standards for nurses working in kidney care.

Sponsors

We would like to extend our appreciation to the following sponsors who have supported this meeting through a payment to exhibit via a stand. The Sponsors will be present at the meeting with promotional stands and have not been involved in any other aspect of this meeting.

	Stanningley Pharma Stanningley Pharma is a privately owned British healthcare company committed to developing products which improve the quality of life for patients in the context of a modernising NHS. The company’s primary interest is the provision of products for people with chronic kidney failure, but it also provides products in other specialist therapeutic areas within hospital medicine. More information about Stanningley Pharma can be found on their website.
	Chiesi Chiesi Farmaceutici is an international research-oriented biopharmaceuticals group with over 85 years’ experience in the pharmaceutical sector. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. Chiesi Limited is headquartered in Manchester employing over 400 people. More information about Chiesi can be found on their website
	AstraZeneca AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca operates in over 100 countries, and its medicines are used by millions of patients worldwide. With a proud 100-year heritage in advancing UK science, today AstraZeneca is the UK’s leading biopharmaceutical company. The company is based in five different locations across the UK, with its global headquarters in Cambridge. In the UK, around 8,700 employees work in research and development, manufacturing, supply, sales, and marketing. We supply around 36 different medicines to the NHS. For more information, please visit www.astrazeneca.co.uk and follow us on Twitter @AstraZenecaUK
	Vantive EXTENDING LIVES >>> EXPANDING POSSIBILITIES We show up every day to expand what’s possible for clinicians in the care they deliver ... and for patients in the lives they live. The next evolution of a kidney care legacy Introducing Vantive, a newly independent healthcare company focused on vital organ therapies. Vantive separated from Baxter in 2025 and is building on a 70-year legacy as a leader in kidney care innovation. As a new standalone company, Vantive is dedicated to advancing vital organ therapies. Greater flexibility and efficiency in therapy administration for care teams, and longer, fuller lives for patients— that is what Vantive aspires to deliver. Over the last seven decades, we have built a legacy of exceptional kidney care products. Now we are deepening our commitment to elevating the dialysis experience through digital solutions and advanced services while evolving our organ support therapies to go beyond kidney care. More information about Vantive can be found on their website.